Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sucampo Pharmaceuticals SCMP

Healthcare Drug Manufacturers - Specialty & Generic
"Sucampo Pharmaceuticals Inc is a part of the healthcare sector in the United States. As a global pharmaceutical company, it commercializes drugs for the treatment of various gastrointestinal, ophthalmic and oncology-based inflammatory disorders. It currently generates revenue mainly from product royalties, product sales, upfront and milestone payments, and reimbursements for development... see more

Recent & Breaking News (NDAQ:SCMP)

Sucampo Standardizes on Veeva Vault for a Single Source of Truth Enterprise-wide

Business Wire April 28, 2016

Sucampo Announces First Quarter 2016 Earnings Call

GlobeNewswire April 20, 2016

Sucampo Reports Top-Line Data from Phase 2a Study of Cobiprostone in Patients with PPI-Refractory Non-Erosive Reflux Disease (NERD) and Symptomatic Gastroesophageal Reflux Disease (sGERD)

GlobeNewswire April 19, 2016

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 28th Annual ROTH Conference

GlobeNewswire March 9, 2016

Sucampo Reports Continued Strong Performance for Fourth Quarter and Full Year 2015

GlobeNewswire March 8, 2016

Sucampo Announces Fourth Quarter and Full Year 2015 Earnings Call

GlobeNewswire February 23, 2016

S&R Foundation Reports 6.2% Stake in Sucampo Pharmaceuticals in 13D

Press Releases February 16, 2016

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2016 Leerink Global Healthcare Conference

GlobeNewswire February 4, 2016

Sucampo Enters Into Exclusive Option and Collaboration Agreement With Cancer Prevention Pharmaceuticals for Development of Late-Stage CPP-1X/Sulindac Combination for Familial Adenomatous Polyposis

GlobeNewswire January 11, 2016

Sucampo Provides Update to 2015 and Confirms 2016 Financial Guidance Post Closing of R-Tech Ueno Acquisition

GlobeNewswire January 7, 2016

Sucampo CEO Peter Greenleaf Appointed Chairman of the Board of Directors

GlobeNewswire December 15, 2015

Sucampo Completes Acquisition of R-Tech Ueno

GlobeNewswire December 7, 2015

Sucampo Announces Webcast of Its Presentation at Piper Jaffray 27th Annual Healthcare Conference

GlobeNewswire November 25, 2015

Mast Therapeutics Announces Appointment Of Peter Greenleaf To Board of Directors

PR Newswire November 9, 2015

Sucampo Reports Third Quarter 2015 Financial Results and Provides Corporate Update

GlobeNewswire November 4, 2015

Sucampo Closes $250 Million Credit Facility

GlobeNewswire October 22, 2015

Sucampo Announces Third Quarter 2015 Earnings Call

GlobeNewswire October 21, 2015

Sucampo Announces Results of Tender Offer for R-Tech Ueno

GlobeNewswire October 14, 2015

Timothy P. Walbert Joins Sucampo's Board of Directors

GlobeNewswire October 13, 2015

Sucampo Launches Tender Offer to Acquire R-Tech Ueno

GlobeNewswire August 26, 2015